GlobeNewswire Inc.··Dndi And SanofiCHMP Endorses Single-Dose Acoziborole for Gambian Sleeping Sickness
CHMP endorses single-dose acoziborole for sleeping sickness, showing 96% efficacy. Sanofi and DNDi developed the treatment, which will be donated to WHO.
SNYacoziborole Winthropsleeping sickness